Thrombolytic therapy and thrombectomy in phlegmasia cerulea dolens.
Thein H
TH
Oo
D000925:Anticoagulants / Q000009:adverse effects; D000991:Antithrombins / Q000008:administration & dosage / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects; D006629:Hirudins; D006801:Humans; D010875:Pipecolic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D013449:Sulfonamides; D017131:Thrombectomy; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors; D020246:Venous Thrombosis / Q000139:chemically induced / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000925:Anticoagulants; D000991:Antithrombins; D005343:Fibrinolytic Agents; D006629:Hirudins; D010875:Pipecolic Acids; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban; C083544:lepirudin